WeVote
Log In

Bill

Bill

SB 2106

EDGE-PHARMACY

104th Regular Session Introduced by Julie Morrison

SB 2106 expands pharmacy services and accessibility in underserved Illinois communities through incentives and regulatory changes to improve medication access and health equity.

Rule 3-9(a) / Re-referred to Assignments
0
WeVote Research Nonpartisan
Bill Summary · SB 2106

Legislative bill overview

SB 2106, the EDGE-Pharmacy bill, establishes a program to expand pharmacy services and accessibility in Illinois, likely through incentives or regulatory changes to encourage pharmacy development in underserved areas. The bill has been in committee review since March 2025 with multiple deadline extensions, suggesting ongoing refinement or deliberation among legislators.

Why is this important

Pharmacy accessibility directly affects public health outcomes, particularly in rural and low-income communities where pharmacy deserts limit medication access and increase healthcare costs. Expanding pharmacy services can improve medication adherence, reduce emergency room visits, and support healthcare equity across Illinois.

Potential points of contention

  • Definition of underserved areas: Disagreement over which communities qualify for incentives and how "EDGE" designation criteria are determined
  • Cost and funding mechanisms: Questions about whether state subsidies, tax incentives, or regulatory changes fund the program and their fiscal impact
  • Scope of pharmacy services: Debate over what expanded services (clinical services, medication therapy management, vaccine administration) are included and how they're regulated

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.